Mitochondrial aberrations in mucolipidosis type IV

被引:113
作者
Jennings, John J., Jr.
Zhu, Jian-hui
Rbaibi, Youssef
Luo, Xiang
Chu, Charleen T.
Kiselyov, Kirill
机构
[1] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA
[4] Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA
关键词
D O I
10.1074/jbc.M607982200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucolipidosis type IV is a genetic lysosomal storage disease associated with degenerative processes in the brain, eye, and other tissues. Mucolipidosis type IV results from mutations in the gene MCOLN1, which codes for the TRP family ion channel, mucolipin 1. The connection between lysosomal dysfunction and degenerative processes in mucolipidosis type IV is unclear. Here we report that mucolipidosis type IV and several unrelated lysosomal storage diseases are associated with significant mitochondrial fragmentation and decreased mitochondrial Ca2+ buffering efficiency. The mitochondrial alterations observed in these lysosomal storage diseases are reproduced in control cells by treatment with lysosomal inhibitors and with the autophagy inhibitor 3-methyladenine. This suggests that inefficient autophagolysosomal recycling of mitochondria generates fragmented, effete mitochondria in mucolipidosis. Mitochondria accumulate that cannot properly buffer calcium fluxes in the cell. A decrease in mitochondrial Ca2+ buffering capacity in cells affected by these lysosomal storage diseases is associated with increased sensitivity to apoptosis induced by Ca2+-mobilizing agonists and executed via a caspase-8-dependent pathway. Deficient Ca2+ homeostasis may represent a common mechanism of degenerative cell death in several lysosomal storage diseases.
引用
收藏
页码:39041 / 39050
页数:10
相关论文
共 71 条
[1]   The neurogenetics of mucolipidosis type IV [J].
Altarescu, G ;
Sun, M ;
Moore, DF ;
Smith, JA ;
Wiggs, EA ;
Solomon, BI ;
Patronas, NJ ;
Frei, KP ;
Gupta, S ;
Kaneski, CR ;
Quarrell, OW ;
Slaugenhaupt, SA ;
Goldin, E ;
Schiffmann, R .
NEUROLOGY, 2002, 59 (03) :306-313
[2]  
Andersson M, 2000, INVEST OPHTH VIS SCI, V41, P2623
[3]  
ARRINGTON D, 2006, IN PRESS AM J PHYSL
[4]   MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis [J].
Asanuma, K ;
Tanida, I ;
Shirato, I ;
Ueno, T ;
Takahara, H ;
Nishitani, T ;
Kominami, E ;
Tomino, Y .
FASEB JOURNAL, 2003, 17 (06) :1165-+
[5]  
Aubry JP, 1999, CYTOMETRY, V37, P197, DOI 10.1002/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO
[6]  
2-L
[7]   Mucolipidosis type IV [J].
Bach, G .
MOLECULAR GENETICS AND METABOLISM, 2001, 73 (03) :197-203
[8]   Mucolipin 1: endocytosis and cation channel - a review [J].
Bach, G .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2005, 451 (01) :313-317
[9]   LYSOSOMAL ACCUMULATION OF PHOSPHOLIPIDS IN MUCOLIPIDOSIS-IV CULTURED FIBROBLASTS [J].
BACH, G ;
DESNICK, RJ .
ENZYME, 1988, 40 (01) :40-44
[10]   PHOSPHATIDYLCHOLINE STORAGE IN MUCOLIPIDOSIS-IV [J].
BARGAL, R ;
BACH, G .
CLINICA CHIMICA ACTA, 1989, 181 (02) :167-174